According to Laboratorio Reig Jofre's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 13.3539. At the end of 2023 the company had a P/E ratio of 18.8.
Year | P/E ratio | Change |
---|---|---|
2023 | 18.8 | -14.38% |
2022 | 21.9 | -52.98% |
2021 | 46.6 | -24.19% |
2020 | 61.4 | 73.39% |
2019 | 35.4 | 117.54% |
2018 | 16.3 | -2.48% |
2017 | 16.7 | -35.77% |
2016 | 26.0 | -92.42% |
2015 | 343 | 1585.75% |
2014 | 20.4 | -79.16% |
2013 | 97.7 | -101.32% |
2012 | < -1000 | -237452.74% |
2011 | 3.12 | -165% |
2010 | -4.80 | 35.06% |
2009 | -3.55 | -103.55% |
2008 | 100 | 265.85% |
2007 | 27.3 | -69.96% |
2006 | 91.0 | 66.97% |
2005 | 54.5 | 17.02% |
2004 | 46.6 |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.